Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118351) titled 'The exploration of the improvement of depressive mood and safety in patients with renal failure secondary to hyperparathyroidism undergoing surgery with low-dose esketamine during the operation' on Feb. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Affiliated Hospital of Anhui Medical University
Condition:
Renal failure leading to hyperparathyroidism
Intervention:
The esketamine experimental group:Dilute 0.25 mg/kg of esketamine to 20 ml. Complete the infusion within 40 minutes after skin incision.
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollmen...